Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Caverject
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Caverject 20microgram inj vials
0704050B0BBAAAA
|
Caverject | Alprostadil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 5,358 |
|
Caverject 10microgram inj vials
0704050B0BBABAI
|
Caverject | Alprostadil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,562 |
|
Caverject Dual Chamber 20microgram inj
0704050B0BBAFBK
|
Caverject | Alprostadil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,568 |
|
Caverject Dual Chamber 10microgram inj
0704050B0BBAEBJ
|
Caverject | Alprostadil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 793 |
|
Caverject 40microgram inj vials
0704050B0BBADBD
|
Caverject | Alprostadil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 406 |
|
Caverject 5microgram inj vials
0704050B0BBACAN
|
Caverject | Alprostadil | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.